tiprankstipranks
Trending News
More News >
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market

Compare Alphamab Oncology (9966) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alphamab Oncology
HK$9.58
HK$8.68B
33.97
175.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$12.33
HK$13.69B
-48.42
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$10.51B
16.10
225.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Abbisko Cayman Limited
HK$13.02
HK$8.50B
44.66
159.34%
2 Buy
0 Hold
0 Sell
Moderate Buy
SinoMab Bioscience Ltd.
HK$1.39
HK$1.87B
-9.46
34.65%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9966
Alphamab Oncology
8.91
5.58
167.57%
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:2142
HBM Holdings Ltd.
11.90
8.16
218.18%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2256
Abbisko Cayman Limited
12.50
7.68
159.34%
HK:3681
SinoMab Bioscience Ltd.
1.36
0.35
34.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts